BlackRock Institutional Trust’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.76M Buy
+43,499
New +$1.71M ﹤0.01% 3099
2016
Q2
Sell
-4,365
Closed -$175K 3944
2016
Q1
$175K Buy
+4,365
New +$175K ﹤0.01% 3641
2015
Q3
Sell
-125,001
Closed -$6.19M 3978
2015
Q2
$6.19M Buy
+125,001
New +$6.34M ﹤0.01% 2677
2015
Q1
Sell
-16,012
Closed -$730K 3891
2014
Q4
$730K Sell
16,012
-4,031
-20% -$196K ﹤0.01% 3422
2014
Q3
$1.13M Buy
20,043
+2,891
+17% +$155K ﹤0.01% 3283
2014
Q2
$912K Buy
17,152
+2,509
+17% +$133K ﹤0.01% 3457
2014
Q1
$766K Buy
14,643
+13,161
+888% +$666K ﹤0.01% 3492
2013
Q4
$79K Sell
1,482
-25,524
-95% -$1.32M ﹤0.01% 3814
2013
Q3
$1.37M Buy
27,006
+24,451
+957% +$1.24M ﹤0.01% 3277
2013
Q2
$132K Buy
+2,555
New +$136K ﹤0.01% 3702

Other funds holding SNY

BlackRock Institutional Trust's SNY Position: Q4 2016 in Review

BlackRock Institutional Trust opened a new position in Sanofi (SNY) in Q4 2016: 43,499 shares worth $1.76M. The stake represents ﹤0.01% of the portfolio and ranks #3099 among its holdings. This is a return to the name: BlackRock Institutional Trust previously reported a position in SNY as recently as Q1 2016.

BlackRock Institutional Trust first reported a position in SNY in Q2 2013 and has held it in 10 quarters since. The position peaked at $6.19M in Q2 2015. 476 funds tracked by Wall St. Rank hold SNY as of Q4 2016.

  • BlackRock Institutional Trust held 43,499 shares of Sanofi worth $1.76M as of Q4 2016.
  • Sanofi was a new BlackRock Institutional Trust position in Q4 2016.
  • Sanofi made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3099 holding.
  • BlackRock Institutional Trust first reported a position in Sanofi in Q2 2013 and has held it in 10 quarters since.
  • BlackRock Institutional Trust's Sanofi position peaked at $6.19M in Q2 2015.
  • 476 funds tracked by Wall St. Rank held Sanofi as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.